🇮🇳 India 🇺🇸 US
All Services Performance Marketing ChatGPT Ads India · NEW Social Media Marketing SEO & AEO / LLM YouTube Marketing LLM Optimization Brand & Growth Consulting AI Solutions Industries We Serve
Enterprise Hub · All Solutions + Services Growth Transformation AI Transformation Revenue Operations Fractional CGO Growth Operating System Executive Growth Advisory
Clinic Launch Programme (Hub) NABH Consulting India Healthcare Brand Launch Clinic SOP Creation Logo Design (Healthcare) Brand Book Creation Clinic Launch Marketing D2C Brand Launch Clinic Interior Design
Workforce Hub For Employers — post a requirement For Professionals — register Public Openings Training Academy AI Training Flagship
Hawk · CRM Intelligence (NEW) YODA · YouTube Intelligence Angryturtle · GBP Intelligence (NEW) Prism Pulse · Instagram Analytics (NEW) Beacon · Attribution Agency OS · Dashboards Phoenix · Clinic Revenue HealthPro 360 · PMS/HMS AI Patient Lifecycle Bots AI Lead Management System Smart Appointment System Healthcare CRM Patient Feedback System AI, Analytics & Automation Digital Transformation Calculators Free Digital Health Audit →
All 13 calculators → 🎯 Business Exploration Matrix (New) Dental Clinic Setup IVF Clinic + Lab Setup Multi-Specialty Hospital Setup Aesthetic / Cosmetology Clinic Dermatology Clinic Setup Generic Clinic Setup Physiotherapy Clinic Setup Diagnostic Centre Setup CAC Calculator CPQL Calculator Franchise ROI Calculator Revenue Leakage Calculator CRM ROI Calculator
All Events Workshop 1 · Jun 13 · AI in Clinical Practice Workshop 2 · Jun 27–28 · AI in Growth & Governance Hospital Ops Workshop · Jul 12 Pre-Summit Seminar · Aug 16 Grand Summit 2.0 · Oct 10–11 Bihar AI Summit · Recap AI Innovation Awards · Aug 22 Grand Summit 2.0 · Oct 2026 Aarambh 2026 Recap
Case Studies Insights & Blog Research Reports Calculators AI in Healthcare Digest
Healthcare Pharma & Life Sciences Other industries
Our Story Leaders @ Ichelon · IN · US · AU Ichelon India · Gurgaon Ichelon Consulting US · Dallas, TX Ichelon Australia · Sydney Speakers & Panelists Client Elevation Programme 🤝 Partner Connect 🇦🇪 ICG UAE Careers
Book a Growth Diagnostic →
We Do It Right. The right diagnosis. The right strategy. The right systems. Giving healthcare leaders the confidence to make better decisions, build stronger operations, and achieve sustainable growth. 🛡️ Goals-Driven & NMC-Compliant Marketing · Get a free NMC compliance audit → — Team Ichelon
Trusted by 150+ healthcare & life-sciences brands
Johnson & Johnson
Mankind Pharma
Adonis Phyto
Narang Biotec
Medanta
Redcliffe Labs
Sitaram Bhartia
Metro Hospitals
Tulasi Hospital
Bloom IVF
Milann
Prime IVF
MedLinks
Handa
Bhardwaj
Eye Q
Johnson & Johnson
Mankind Pharma
Adonis Phyto
Narang Biotec
Medanta
Redcliffe Labs
Sitaram Bhartia
Metro Hospitals
Tulasi Hospital
Bloom IVF
Milann
Prime IVF
MedLinks
Handa
Bhardwaj
Eye Q
Johnson & Johnson
Mankind Pharma
Adonis Phyto
Narang Biotec
Medanta
Redcliffe Labs
Sitaram Bhartia
Metro Hospitals
Tulasi Hospital
Bloom IVF
Milann
Prime IVF
MedLinks
Handa
Bhardwaj
Eye Q
Compliance · AYUSH · India 2026

AYUSH Advertising Compliance Guide for Doctors and Clinics — India 2026

Published 5 September 2026 · · 12 min read
AYUSH advertising sits at the intersection of three overlapping rulebooks — a central Act from 1954, Ministry of AYUSH guidance, and a state council that may read both differently from its neighbour. Most clinics find out which rule mattered only after an ad gets pulled or a council notice arrives. This guide lays out the actual compliance stack, the claims that get flagged most often, and a cheat sheet you can hand to whoever writes your next ad.
TL;DR
  • The Drugs and Magic Remedies Act, 1954 governs every AYUSH advertisement in India and bans cure-claims for a specific schedule of conditions, regardless of which system of medicine is advertising.
  • Ministry of AYUSH guidance and state councils add a second, often stricter layer — and state councils do not interpret testimonial and before-after rules identically.
  • The three claim categories that get flagged most often are cure-claims, before-after visuals, and named patient testimonials describing an outcome.
  • Ad platforms reject non-compliant AYUSH health content independently of legal risk — a claim can be perfectly legal and still get an account restricted.
  • A single centrally-reviewed claims library, applied to the strictest state standard your chain operates under, is the most scalable way to stay compliant across locations.

The three-layer compliance stack every AYUSH advertiser is actually operating under

Ask five AYUSH clinic owners which law governs their advertising and you will typically get three different answers, and none of the five will name all three layers that actually apply. The confusion is understandable — the stack was not designed as a single coherent system, and it does not read like one.

Layer one is the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 — a central law that predates independence-era health regulation reform by decades and still governs every advertisement for the treatment, diagnosis, cure, or prevention of any disease in its schedule, across all systems of medicine. It does not carve out an exception for Ayurveda, Siddha, Unani, or Homeopathy. If anything, enforcement attention on AYUSH advertising under this Act has increased through 2024 to 2026 as digital ad volume in the sector grew.

Layer two is Ministry of AYUSH guidance and the product-advertisement provisions under the Drugs and Cosmetics framework, which apply most directly to manufactured AYUSH products and formulations but shape how a clinic can describe the therapies it offers alongside them.

Layer three is state-level professional conduct — enforced by state Ayurveda, Unani, Siddha, and Homeopathy councils, which register practitioners and can act against a doctor's registration for advertising conduct the council considers unprofessional, independent of whether the DMR Act was technically violated. This is the layer most clinics underweight, and it is also the layer with the most variance state to state.

A clinic that only checks layer one and assumes it is covered is missing the two layers most likely to actually generate a real-world consequence in 2026 — a platform takedown from a policy layer none of the three technically govern, or a council notice from layer three.

Where state councils actually disagree

The DMR Act schedule of prohibited disease-cure claims is national and does not vary. What varies is how strictly a state council reads adjacent conduct — testimonials, before-after content, and use of the word "cure" in softer framing.

Council postureTypical stance on testimonialsTypical stance on before-after content
Strict-interpretation statesTreated as a DMR-adjacent violation even without an explicit disease-cure claim in the testimonial textProhibited outright, including generic "wellness journey" framing
Moderate-interpretation statesAllowed if the testimonial avoids naming a specific disease or guaranteed outcomeDiscouraged but not uniformly enforced; council action tends to follow a complaint, not proactive review
Under-enforced statesRarely actioned unless a complaint is filed, but the underlying rule still exists and can be invokedRarely actioned proactively, same caveat

This variance is precisely why a chain operating across four or five states cannot safely run one ad creative everywhere. The moment a testimonial-led campaign that performed well in a moderate-interpretation state gets reused in a strict-interpretation one, the clinic has exposure it did not have a week earlier — with no change to the underlying medicine or claim, only to which council is reading it.

Claim discipline — the framework that actually holds up

Every AYUSH ad, landing page, and social post can be tested against three questions before it goes live. If any answer is "yes," the content needs rework before publishing, not after a complaint.

  1. Does it name a specific disease and imply cure, reversal, or elimination? "Manage joint discomfort through Panchakarma-based therapy" passes. "Cure arthritis permanently with our Panchakarma programme" does not.
  2. Does it show or describe a before-after outcome tied to an individual? This includes photos, videos, and written testimonials with specificity — "60 percent improvement in three weeks" is a before-after claim even without a photo.
  3. Does it create urgency or guarantee framing that a reasonable viewer would read as a promise? "Limited slots — guaranteed results" combines two separate risk flags in one line.

The safest replacement pattern across all three is educational-and-general: describe the therapy category, the conditions it is traditionally used to support, and a general wellness framing — then close with an invitation to consult, not a claim of outcome. This pattern satisfies the DMR Act, tends to satisfy the stricter state councils, and is also the pattern ad platforms approve most reliably for health-adjacent verticals, which matters independently of the legal question.

The common violations we see most often in AYUSH ad audits

None of these six require malicious intent to trigger. Almost every case we have audited came from a well-meaning marketing team optimising for click-through rate without a compliance pass built into the ad-review workflow — which is the actual fix, not writer intent.

Building the review workflow that catches this before publish

Compliance that lives only in a person's head does not survive team turnover, agency handoffs, or a busy launch week. The workflow that holds looks like this: every ad, landing page, and organic post passes through a claims checklist before it is scheduled — not after a complaint arrives. The checklist should be short enough that a marketing team actually uses it: the three-question claim-discipline test above, plus a state-specific check against the strictest council standard the clinic operates under.

For a multi-location AYUSH chain, the highest-leverage single investment is a centrally-maintained claims library — pre-approved phrasing for each therapy category, each condition area, and each state variant — that local teams pull from rather than writing fresh copy under deadline pressure. This is the same discipline our branding and messaging engagements build for regulated healthcare categories, and it is one of the review layers we build into every paid ads management engagement in the AYUSH and wellness vertical, because a platform-rejected ad and a council-flagged ad are usually caught by the same upstream checklist.

The pattern worth internalisingCompliance risk in AYUSH advertising rarely comes from one dramatic claim. It comes from a dozen small, individually plausible phrasing choices made under deadline pressure, none of which got a second read. Fix the review step, not the writer.

What ICG does here

Inside our healthcare marketing engagements for AYUSH clinics and multi-location chains, compliance review is not a separate add-on — it is built into how ads, landing pages, and organic content get produced in the first place. Our paid ads management team runs every AYUSH campaign through a claims checklist before it goes live, mapped to the strictest state council standard the client operates under, so a creative that works in one city does not create exposure in another. Our branding work builds the centrally-maintained claims library that keeps local teams from writing fresh, unreviewed copy under launch pressure. We also review existing ad accounts and landing pages for the six common-violation patterns above as a standalone audit, independent of whether a client engages us for ongoing management. Retainers from Rs 20,000/month, custom-scoped per engagement.

Cheat sheet — keep this next to your ad-review desk

Before you publish, check for:

  • Disease name + cure/reverse/eliminate language together
  • Named testimonial with a specific health outcome
  • Before-after image, video, or written comparison tied to an individual
  • Comparative superiority claim against another system of medicine
  • Credential or registration claim not currently held
  • Urgency or guarantee language stacked with a disease-specific promise
  • Content written for the most lenient state, not the strictest one your chain operates under

If any box is checked, hold the content and rewrite to the educational-and-general pattern before scheduling.

Get your AYUSH ad accounts audited before the next campaign goes live

We will review your last 90 days of ads and landing pages against the DMR Act, Ministry of AYUSH guidance, and the strictest state council standard your locations touch — and hand you a fixed claims library your team can reuse going forward.

Chat with Co-founder WhatsApp ICG

FAQ

Does the Drugs and Magic Remedies Act apply to AYUSH clinic advertising?

Yes. The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, applies across all systems of medicine, including Ayurveda, Siddha, Unani, and Homeopathy. It prohibits advertisements claiming a cure for the conditions listed in its schedule, such as cancer, diabetes, and sexual disorders, regardless of the therapeutic system making the claim.

Can an AYUSH doctor advertise on Google and Meta in 2026?

Yes, provided the ad content stays within educational and informational bounds — clinic identity, qualifications, general wellness information, and appointment booking. Ads naming specific disease cures, before-after outcomes, or guaranteed results are routinely rejected by ad platform health-content review and separately expose the clinic to DMR Act liability.

Do state AYUSH councils have different advertising rules than the central Ministry of AYUSH?

Yes. The Ministry of AYUSH sets national guidance and product-advertisement rules under the Drugs and Cosmetics framework, but professional conduct and advertising discipline for individual practitioners is enforced by state-level Ayurveda, Unani, Siddha, and Homeopathy councils, which vary in how strictly they interpret testimonial and before-after restrictions.

Are patient testimonials allowed in AYUSH clinic marketing?

Named, on-camera patient testimonials describing a cure or outcome are the single most cited violation across state council actions and platform takedowns. Generic, outcome-free patient experience content without disease-cure framing carries materially lower risk, but most compliance teams recommend avoiding testimonials altogether for AYUSH advertising.

What happens if an AYUSH clinic runs a non-compliant ad?

Consequences range from ad platform rejection or account-level health-vertical restrictions, to state council show-cause notices and, under the DMR Act, criminal liability including fines and imprisonment for repeat offences. Most real-world enforcement in 2026 is platform-side takedown rather than criminal prosecution, but council action against the practitioner's registration is a real and growing risk.

What is the safest advertising framework for an AYUSH clinic chain operating in multiple states?

Write every ad and landing page to the strictest applicable state council standard, not the most lenient one, then layer in DMR Act and platform-policy review as a second gate. A single centrally-reviewed claims library, reused across states with only branch-specific detail changed, is the most scalable way multi-state chains stay compliant without slowing every local campaign down.

Related reading

· Published under ICG Editorial Standards · Questions? WhatsApp the author.
Sources & methodology +

Primary data — ICG's live client portfolio (150+ healthcare brands, 12+ specialties, since 2018): CPQL, EMQ, lead-to-consult conversion, cohort MRR:CAC. All numbers are portfolio aggregates unless a specific client is named.

Platform data — Google Search Console (impressions, CTR, position), Google Analytics 4 (session behaviour, conversion paths), Meta Ads Manager (EMQ, CTWA, CAPI event quality), Google Ads (search terms, quality score, intent-tier classification), Angryturtle GBP portfolio (143 listings under management).

Regulatory sources — NMC Guidelines on Ethical Advertising and Public Communication (2026), DPDP Act 2023, ART (Regulation) Act 2021, NABH 6th Edition, ASCI Healthcare Guidelines — cited when the article references compliance obligations. Regulatory interpretations are current as of the article's last-updated date.

Third-party research — When cited, sources are named inline (PwC India Healthcare, McKinsey Life Sciences, etc.) with the publication year. If a stat has no citation, it comes from ICG's own portfolio.

Methodology transparency — See /about/methodology for the diagnostic framework used to produce these insights, and /editorial-standards for the fact-check + review workflow every published article goes through.

Related reading
Insight
Hindi and regional-language SEO for Indian clinics and hospitals
Insight
Launching a new pharma brand in India: a six-month digital plan
Insight
NMC's October 2026 advertising guidelines: what clinics and hospitals must change now
All 125+ ICG insights →
Chat with Co-founder
Goals-Driven & NMC-Compliant Marketing · Performance-Linked Payout Models Chat with Co-founder